schliessen

Filtern

 

Bibliotheken

A novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy

Our aim in this study was to develop a prognostic scoring system with which to identify patients most likely to benefit from adjuvant chemolipiodolization (ACL) after liver resection for hepatocellular carcinoma (HCC). Data from 1150 HCC patients who underwent liver resection between 2002 and 2008 a... Full description

Journal Title: Oncotarget 03 May 2016, Vol.7(18), pp.25493-506
Main Author: Huang, Li-Feng
Other Authors: Xing, Xianglei , Wu, Dong , Xia, Yong , Li, Jun , Wang, Kui , Yan, Zhen-Lin , Wan, Xu-Ying , Shi, Le-Hua , Yang, Tian , Lau, Wan Yee , Wu, Meng-Chao , Shen, Feng
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1949-2553 ; PMID: 27027439 Version:1 ; DOI: 10.18632/oncotarget.8333
Link: http://pubmed.gov/27027439
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: medline27027439
title: A novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy
format: Article
creator:
  • Huang, Li-Feng
  • Xing, Xianglei
  • Wu, Dong
  • Xia, Yong
  • Li, Jun
  • Wang, Kui
  • Yan, Zhen-Lin
  • Wan, Xu-Ying
  • Shi, Le-Hua
  • Yang, Tian
  • Lau, Wan Yee
  • Wu, Meng-Chao
  • Shen, Feng
subjects:
  • Adjuvant Chemolipiodolization
  • Hepatocellular Carcinoma
  • Liver Resection
  • Prognosis
  • Scoring System
  • Carcinoma, Hepatocellular -- Therapy
  • Liver Neoplasms -- Therapy
ispartof: Oncotarget, 03 May 2016, Vol.7(18), pp.25493-506
description: Our aim in this study was to develop a prognostic scoring system with which to identify patients most likely to benefit from adjuvant chemolipiodolization (ACL) after liver resection for hepatocellular carcinoma (HCC). Data from 1150 HCC patients who underwent liver resection between 2002 and 2008 at the Eastern Hepatobiliary Surgery Hospital were used to develop the scoring system. Patients were stratified into prognostic subgroups using the new scoring system, and the outcomes of patients who received ACL and those who did not were compared in each subgroup. Using data from 379 patients operated on between 2008 and 2010 for validation, the scoring system had a concordance index (C-index) of 0.75 for predicting post-resectional overall survival (OS). It optimally stratified patients into three prognostic subgroups with scores of 0-5, 6-9 and ≥ 10, having better, medium and worse survival outcomes, respectively. A difference in OS between ACL and non-ACL patients was only detected in the...
language: eng
source:
identifier: E-ISSN: 1949-2553 ; PMID: 27027439 Version:1 ; DOI: 10.18632/oncotarget.8333
fulltext: fulltext
issn:
  • 19492553
  • 1949-2553
url: Link


@attributes
ID310898451
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid27027439
sourceidmedline
recordidTN_medline27027439
sourceformatXML
sourcesystemPC
pqid1812878490
display
typearticle
titleA novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy
creatorHuang, Li-Feng ; Xing, Xianglei ; Wu, Dong ; Xia, Yong ; Li, Jun ; Wang, Kui ; Yan, Zhen-Lin ; Wan, Xu-Ying ; Shi, Le-Hua ; Yang, Tian ; Lau, Wan Yee ; Wu, Meng-Chao ; Shen, Feng
ispartofOncotarget, 03 May 2016, Vol.7(18), pp.25493-506
identifier
subjectAdjuvant Chemolipiodolization ; Hepatocellular Carcinoma ; Liver Resection ; Prognosis ; Scoring System ; Carcinoma, Hepatocellular -- Therapy ; Liver Neoplasms -- Therapy
descriptionOur aim in this study was to develop a prognostic scoring system with which to identify patients most likely to benefit from adjuvant chemolipiodolization (ACL) after liver resection for hepatocellular carcinoma (HCC). Data from 1150 HCC patients who underwent liver resection between 2002 and 2008 at the Eastern Hepatobiliary Surgery Hospital were used to develop the scoring system. Patients were stratified into prognostic subgroups using the new scoring system, and the outcomes of patients who received ACL and those who did not were compared in each subgroup. Using data from 379 patients operated on between 2008 and 2010 for validation, the scoring system had a concordance index (C-index) of 0.75 for predicting post-resectional overall survival (OS). It optimally stratified patients into three prognostic subgroups with scores of 0-5, 6-9 and ≥ 10, having better, medium and worse survival outcomes, respectively. A difference in OS between ACL and non-ACL patients was only detected in the...
languageeng
source
version4
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://pubmed.gov/27027439$$EView_this_record_in_MEDLINE/PubMed
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutMedline.html$$EView_the_MEDLINE/PubMed_Copyright_Statement
search
creatorcontrib
0Huang, Li-Feng
1Xing, Xianglei
2Wu, Dong
3Xia, Yong
4Li, Jun
5Wang, Kui
6Yan, Zhen-Lin
7Wan, Xu-Ying
8Shi, Le-Hua
9Yang, Tian
10Lau, Wan Yee
11Wu, Meng-Chao
12Shen, Feng
titleA novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy
descriptionOur aim in this study was to develop a prognostic scoring system with which to identify patients most likely to benefit from adjuvant chemolipiodolization (ACL) after liver resection for hepatocellular carcinoma (HCC). Data from 1150 HCC patients who underwent liver resection between 2002 and 2008 at the Eastern Hepatobiliary Surgery Hospital were used to develop the scoring system. Patients were stratified into prognostic subgroups using the new scoring system, and the outcomes of patients who received ACL and those who did not were compared in each subgroup. Using data from 379 patients operated on between 2008 and 2010 for validation, the scoring system had a concordance index (C-index) of 0.75 for predicting post-resectional overall survival (OS). It optimally stratified patients into three prognostic subgroups with scores of 0-5, 6-9 and ≥ 10, having better, medium and worse survival outcomes, respectively. A difference in OS between ACL and non-ACL patients was only detected in the...
subject
0Adjuvant Chemolipiodolization
1Hepatocellular Carcinoma
2Liver Resection
3Prognosis
4Scoring System
5Carcinoma, Hepatocellular -- Therapy
6Liver Neoplasms -- Therapy
general
027027439
1English
2MEDLINE/PubMed (U.S. National Library of Medicine)
310.18632/oncotarget.8333
4MEDLINE/PubMed (NLM)
sourceidmedline
recordidmedline27027439
issn
019492553
11949-2553
rsrctypearticle
creationdate2016
addtitleOncotarget
searchscope
0medline
1nlm_medline
2MEDLINE
scope
0medline
1nlm_medline
2MEDLINE
lsr4120160503
citationpf 25493 vol 7 issue 18
startdate20160503
enddate20160503
lsr30VSR-Enriched:[pages, pqid]
sort
titleA novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy
authorHuang, Li-Feng ; Xing, Xianglei ; Wu, Dong ; Xia, Yong ; Li, Jun ; Wang, Kui ; Yan, Zhen-Lin ; Wan, Xu-Ying ; Shi, Le-Hua ; Yang, Tian ; Lau, Wan Yee ; Wu, Meng-Chao ; Shen, Feng
creationdate20160503
lso0120160503
facets
frbrgroupid-1686425701425894922
frbrtype5
newrecords20190701
languageeng
creationdate2016
topic
0Adjuvant Chemolipiodolization
1Hepatocellular Carcinoma
2Liver Resection
3Prognosis
4Scoring System
5Carcinoma, Hepatocellular–Therapy
6Liver Neoplasms–Therapy
collectionMEDLINE/PubMed (NLM)
prefilterarticles
rsrctypearticles
creatorcontrib
0Huang, Li-Feng
1Xing, Xianglei
2Wu, Dong
3Xia, Yong
4Li, Jun
5Wang, Kui
6Yan, Zhen-Lin
7Wan, Xu-Ying
8Shi, Le-Hua
9Yang, Tian
10Lau, Wan Yee
11Wu, Meng-Chao
12Shen, Feng
jtitleOncotarget
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Huang
1Xing
2Wu
3Xia
4Li
5Wang
6Yan
7Wan
8Shi
9Yang
10Lau
11Shen
aufirst
0Li-Feng
1Xianglei
2Dong
3Yong
4Jun
5Kui
6Zhen-Lin
7Xu-Ying
8Le-Hua
9Tian
10Wan Yee
11Meng-Chao
12Feng
au
0Huang, Li-Feng
1Xing, Xianglei
2Wu, Dong
3Xia, Yong
4Li, Jun
5Wang, Kui
6Yan, Zhen-Lin
7Wan, Xu-Ying
8Shi, Le-Hua
9Yang, Tian
10Lau, Wan Yee
11Wu, Meng-Chao
12Shen, Feng
atitleA novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy
jtitleOncotarget
risdate20160503
volume7
issue18
spage25493
pages25493-25506
issn1949-2553
eissn1949-2553
formatjournal
genrearticle
ristypeJOUR
abstractOur aim in this study was to develop a prognostic scoring system with which to identify patients most likely to benefit from adjuvant chemolipiodolization (ACL) after liver resection for hepatocellular carcinoma (HCC). Data from 1150 HCC patients who underwent liver resection between 2002 and 2008 at the Eastern Hepatobiliary Surgery Hospital were used to develop the scoring system. Patients were stratified into prognostic subgroups using the new scoring system, and the outcomes of patients who received ACL and those who did not were compared in each subgroup. Using data from 379 patients operated on between 2008 and 2010 for validation, the scoring system had a concordance index (C-index) of 0.75 for predicting post-resectional overall survival (OS). It optimally stratified patients into three prognostic subgroups with scores of 0-5, 6-9 and ≥ 10, having better, medium and worse survival outcomes, respectively. A difference in OS between ACL and non-ACL patients was only detected in the...
doi10.18632/oncotarget.8333
pmid27027439
date2016-05-03